Search company, investor...

Farmabios

farmabios.net

Stage

Private Equity | Alive

Total Raised

$14.64M

About Farmabios

Developer of pharmaceutical raw materials. The company develops and produces steroids, sterile steroids, semi-synthetic cephalosporins, sterile semi-synthetic cephalosporins, and high potent substances, as well as antibiotics, amifostine, formotorol, mevacurium chloride, and rocuronium bromide. The company also provides custom synthesis services to companies specializing in the identification and development of new chemical entities.

Headquarters Location

Via Pavia 1 Gropello Cairoli

Pavia, 27027,

Italy

39 03 828191

Missing: Farmabios's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Farmabios's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Farmabios Patents

Farmabios has filed 1 patent.

The 3 most popular patent topics include:

  • Antiestrogens
  • Estranes
  • Hormonal antineoplastic drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/31/2019

7/14/2020

Pregnanes, Neurosteroids, Sedatives, Ketones, Anxiolytics

Grant

Application Date

7/31/2019

Grant Date

7/14/2020

Title

Related Topics

Pregnanes, Neurosteroids, Sedatives, Ketones, Anxiolytics

Status

Grant

Latest Farmabios News

Farmabios, Novasep and PharmaZell are now Axplora

Oct 21, 2022

Farmabios, Novasep and PharmaZell are now Axplora Search jobs Farmabios, Novasep and PharmaZell are now Axplora   Following the merger of Novasep and PharmaZell Group in April 2022, the Farmabios, Novasep and PharmaZell brands are now being unified under a single name. The merger brings together companies that share a track record of high quality, reliability and a complementary set of differentiated technologies. The name Axplora reflects the ambition to be the partner of choice for complex APIs. It conveys the Axplora spirit and agility, underpinned by an innovative mindset which drives the company and its employees. Raubling, 20 October 2022 – Farmabios, Novasep and PharmaZell officially announced today that they are coming together under the new brand Axplora. This announcement comes just 6 months after the closure of the merger of the Novasep and the PharmaZell Group. This marks the last step in the creation of Axplora, a leading Active Pharmaceutical Ingredients (API) manufacturing partner for pharmaceutical and biotechnology companies worldwide, with a long track record of reliably developing and scaling up complex production processes and delivering medicines on time and at scale, to the highest industry standards. The creation of Axplora is the result of a carefully thought-out process: the new brand illustrates the innovative mindset driving the company and its employees. The tagline “Reliable partner. Agile explorer.” encapsulates the explorer spirit that the company fosters within the organisation and with our partners. It also refers to the pharmaceutical lifecycle to find API solutions in a reliable, safe, efficient, and sustainable way for patients. With the Farmabios, Novasep and PharmaZell brands being unified under a single name, Axplora brings together companies that share a track record of high quality, reliability and a complementary set of differentiated technologies. The merged company is leveraging technology and knowledge to deliver the full customer-centred lifecycle from innovation to generics. It will offer added security of supply for clients at the highest standards. With nine industrial sites in Europe and India and an R&D facility in the USA, its global footprint enables Axplora to optimize supply chain logistics. Dr. Sylke Hassel, CEO of Axplora says: “I am very proud to reveal our new name today, Axplora, to take this step alongside our teams for our partners and customers. Under this new name, thanks to our talented staff, Axplora will provide the highest quality manufacturing solutions that will enable our customers to improve their patients’ quality of life, wherever they live in the world, and whatever their therapeutic need - across the full spectrum of the pharmaceutical development lifecycle.” Editor Details

Farmabios Frequently Asked Questions (FAQ)

  • Where is Farmabios's headquarters?

    Farmabios's headquarters is located at Via Pavia 1, Pavia.

  • What is Farmabios's latest funding round?

    Farmabios's latest funding round is Private Equity.

  • How much did Farmabios raise?

    Farmabios raised a total of $14.64M.

  • Who are the investors of Farmabios?

    Investors of Farmabios include Ergon Capital Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.